VVM Vivomedica

    RNS Number : 9250C
  Vivomedica PLC
  08 September 2008
   

 For immediate release  8 September 2008

    VivoMedica plc
    ("VivoMedica" or the "Company")

    Annual General Meeting Result

    VivoMedica plc (AIM:VVM) the pharmaware company, announces that all the resolutions were duly passed at the Company's Annual General
Meeting held today.

    A summary of proxy votes for each Resolution is below.

    
 Resolution                                               Percentage Votes For
 1. To receive and adopt the financial statements for                    99.6%
 the year ended 31 December 2007
 2. To re-appoint KPMG Audit Plc as Auditors of the                      99.9%
 Company
 3. To re-elect, as a Director, Peter Leyland                            98.7%
 4. To re-elect, as a Director, Alan Edwards                             98.7%
 5. To re-elect, as a Director, Susan Veness                             98.6%
 6. To authorise the Directors to allot relevant                         97.6%
 securities
 7. That the Directors be generally empowered pursuant                   96.5%
 to Section 95 of the Act to allot equity securities



    For further information, please contact:

    
 VivoMedicaPeter Leyland, Chief Executive OfficerSusan Veness,    01795 414460
 Finance Director
                                                                              
 Brewin Dolphin Investment Banking (NOMAD)Mark Brady / Alison    0845 270 8600
 Barrow
                                                                              
 Buchanan CommunicationsTim Anderson / Catherine Breen           020 7466 5000
                                                                              



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
RAGKGGGLLRGGRZG

Grafico Azioni Vivomedica (LSE:VVM)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Vivomedica (LSE:VVM)
Storico
Da Giu 2023 a Giu 2024